Utah Medical Products Inc... (UTMD)
Utah Medical Products Statistics
Share Statistics
Utah Medical Products has 3.28M shares outstanding. The number of shares has increased by -6.99% in one year.
| Shares Outstanding | 3.28M |
| Shares Change (YoY) | -6.99% |
| Shares Change (QoQ) | -3.24% |
| Owned by Institutions (%) | 66.04% |
| Shares Floating | 3.06M |
| Failed to Deliver (FTD) Shares | 68 |
| FTD / Avg. Volume | 0.32% |
Short Selling Information
The latest short interest is 75.72K, so 2.23% of the outstanding shares have been sold short.
| Short Interest | 75.72K |
| Short % of Shares Out | 2.23% |
| Short % of Float | 2.4% |
| Short Ratio (days to cover) | 3.39 |
Valuation Ratios
The PE ratio is 15.52 and the forward PE ratio is null. Utah Medical Products's PEG ratio is -1.16.
| PE Ratio | 15.52 |
| Forward PE | n/a |
| PS Ratio | 5.26 |
| Forward PS | 1.9 |
| PB Ratio | 1.83 |
| P/FCF Ratio | 0 |
| PEG Ratio | -1.16 |
Enterprise Valuation
Utah Medical Products has an Enterprise Value (EV) of 132.64M.
| EV / Sales | 3.24 |
| EV / EBITDA | 8.07 |
| EV / EBIT | 0 |
| EV / FCF | 0 |
Financial Position
The company has a current ratio of 25.64, with a Debt / Equity ratio of 0.
| Current Ratio | 25.64 |
| Quick Ratio | 23.29 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | - |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 11.81% and Return on Invested Capital is 9.45%.
| Return on Equity | 11.81% |
| Return on Assets | 11.32% |
| Return on Invested Capital | 9.45% |
| Revenue Per Employee | $263.89K |
| Profits Per Employee | $89.51K |
| Employee Count | 155 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 1.9 |
Taxes
| Income Tax | 2.93M |
| Effective Tax Rate | 17.43% |
Stock Price Statistics
The stock price has increased by -18.14% in the last 52 weeks. The beta is 0.06, so Utah Medical Products's price volatility has been higher than the market average.
| Beta | 0.06 |
| 52-Week Price Change | -18.14% |
| 50-Day Moving Average | 59.36 |
| 200-Day Moving Average | 64.28 |
| Relative Strength Index (RSI) | 23.24 |
| Average Volume (20 Days) | 21.05K |
Income Statement
In the last 12 months, Utah Medical Products had revenue of 40.9M and earned 13.87M in profits. Earnings per share was 3.96.
| Revenue | 40.9M |
| Gross Profit | 24.14M |
| Operating Income | 13.59M |
| Net Income | 13.87M |
| EBITDA | 16.44M |
| EBIT | 13.59M |
| Earnings Per Share (EPS) | 3.96 |
Balance Sheet
The company has 82.98M in cash and 282K in debt, giving a net cash position of 82.69M.
| Cash & Cash Equivalents | 82.98M |
| Total Debt | 282K |
| Net Cash | 82.69M |
| Retained Earnings | 0 |
| Total Assets | 122.54M |
| Working Capital | 92.57M |
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0.
| Operating Cash Flow | 0 |
| Capital Expenditures | 0 |
| Free Cash Flow | 0 |
| FCF Per Share | 0 |
Margins
Gross margin is 59.03%, with operating and profit margins of 33.23% and 33.92%.
| Gross Margin | 59.03% |
| Operating Margin | 33.23% |
| Pretax Margin | 41.08% |
| Profit Margin | 33.92% |
| EBITDA Margin | 40.19% |
| EBIT Margin | 33.23% |
| FCF Margin | n/a |
Dividends & Yields
UTMD pays an annual dividend of $1.51, which amounts to a dividend yield of 2.11%.
| Dividend Per Share | $1.51 |
| Dividend Yield | 2.11% |
| Dividend Growth (YoY) | 1.67% |
| Payout Ratio | 38.13% |
| Earnings Yield | 6.44% |
| FCF Yield | 0% |
Analyst Forecast
Currently there are no analyst rating for UTMD.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Mar 22, 1993. It was a forward split with a ratio of 3:2.
| Last Split Date | Mar 22, 1993 |
| Split Type | forward |
| Split Ratio | 3:2 |
Scores
| Altman Z-Score | 23.2 |
| Piotroski F-Score | 7 |